Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer With Intermediate Risk”

186 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 186 results

Large-scale testing (Phase 3)Study completedNCT00936390
What this trial is testing

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,538
Not applicableWithdrawnNCT02546427
What this trial is testing

Hypofractionated Whole Pelvic Radiotherapy of the Prostate

Who this might be right for
Prostate Cancer
Albert J. Chang
Not applicableStudy completedNCT02618161
What this trial is testing

Timing of HDR With EBRT in Localised Prostate Cancer,Toxicity and Quality of Life Assessment

Who this might be right for
Prostate Cancer
Mid and South Essex NHS Foundation Trust 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT06855589
What this trial is testing

Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Charles LeMoyne Hospital 400
Not applicableEnded earlyNCT02454517
What this trial is testing

Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer AJCC V7Stage IIA Prostate Cancer AJCC v7
Fred Hutchinson Cancer Center 117
Not applicableNot Yet RecruitingNCT07460726
What this trial is testing

PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)Erectile AbnormalitiesSexual Dysfunction Male
CancerCare Manitoba 130
Not applicableLooking for participantsNCT07219303
What this trial is testing

Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Fox Chase Cancer Center 80
Not applicableStudy completedNCT00573833
What this trial is testing

Internal Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 23
Large-scale testing (Phase 3)Active Not RecruitingNCT06235151
What this trial is testing

Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Curium US LLC 439
Testing effectiveness (Phase 2)UnknownNCT01909388
What this trial is testing

Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy

Who this might be right for
Prostate Cancer
Alfonso Gomez-Iturriaga 15
Large-scale testing (Phase 3)Study completedNCT04627896
What this trial is testing

Targeted Microwave Focal Therapy

Who this might be right for
Prostate Cancer Stage I
A.O.U. Città della Salute e della Scienza 11
Not applicableLooking for participantsNCT05832736
What this trial is testing

Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer

Who this might be right for
Prostate Cancer
Fondazione del Piemonte per l'Oncologia 36
Testing effectiveness (Phase 2)Study completedNCT02770391
What this trial is testing

Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 54
Not applicableLooking for participantsNCT05722392
What this trial is testing

Safety and Efficacy of Two-step Radical Prostatectomy

Who this might be right for
Prostate Cancer
Sun Yat-sen University 30
Testing effectiveness (Phase 2)UnknownNCT02165020
What this trial is testing

Hyaluronic Acid for Hypofractionated Prostate Radiotherapy

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 36
Large-scale testing (Phase 3)UnknownNCT01839994
What this trial is testing

Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Maria Sklodowska-Curie National Research Institute of Oncology 350
Testing effectiveness (Phase 2)WithdrawnNCT04020094
What this trial is testing

Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
University of Utah
Early research (Phase 1)Study completedNCT00026377
What this trial is testing

SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Chicago 3
Not applicableActive Not RecruitingNCT05628363
What this trial is testing

Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer

Who this might be right for
Prostate CancerCancer of the Prostate
Washington University School of Medicine 28
Testing effectiveness (Phase 2)Study completedNCT00547339
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center 94
Next Page